Cargando…

Critical appraisal of the role of davunetide in the treatment of progressive supranuclear palsy

Progressive supranuclear palsy (PSP) is a rare neurodegenerative disease characterized by the accumulation of tau protein aggregates in the basal ganglia, brainstem and cerebral cortex leading to rapid disease progression and death. The neurofibrillary tangles that define the neuropathology of PSP a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gold, Michael, Lorenzl, Stefan, Stewart, Alistair J, Morimoto, Bruce H, Williams, David R, Gozes, Illana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Expert Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3280109/ https://www.ncbi.nlm.nih.gov/pubmed/22347799 http://dx.doi.org/10.2147/NDT.S12518

Ejemplares similares

Unexpected gender differences in progressive supranuclear palsy reveal efficacy for davunetide in women
por: Gozes, Illana, et al.
Publicado: (2023)

Intranasal NAP (davunetide) decreases tau hyperphosphorylation and moderately improves behavioral deficits in mice overexpressing α-synuclein
por: Magen, Iddo, et al.
Publicado: (2014)

New treatment options for fibromyalgia: critical appraisal of duloxetine
por: Üçeyler, Nurcan, et al.
Publicado: (2008)

NAP (davunetide) preferential interaction with dynamic 3-repeat Tau explains differential protection in selected tauopathies
por: Ivashko-Pachima, Yanina, et al.
Publicado: (2019)

Critical appraisal of the long-term impact of memantine in treatment of moderate to severe Alzheimer’s disease
por: Puangthong, Umamon, et al.
Publicado: (2009)

NAP (Davunetide): The Neuroprotective ADNP Drug Candidate Penetrates Cell Nuclei Explaining Pleiotropic Mechanisms
por: Ganaiem, Maram, et al.
Publicado: (2023)

New and extended-action treatments in the management of ADHD: a critical appraisal of lisdexamfetamine in adults and children
por: Domnitei, Diana, et al.
Publicado: (2010)

Critical appraisal and update on the clinical utility of agomelatine, a melatonergic agonist, for the treatment of major depressive disease in adults
por: Howland, Robert H
Publicado: (2009)

Cerebral palsy and sleep disordered breathing
por: Morley, Andrew
Publicado: (2016)

No Evidence of a Contribution of the Vestibular System to Frequent Falls in Progressive Supranuclear Palsy
por: Goldschagg, Nicolina, et al.
Publicado: (2019)

Neck Vibration Proprioceptive Postural Response Intact in Progressive Supranuclear Palsy unlike Idiopathic Parkinson’s Disease
por: Kammermeier, Stefan, et al.
Publicado: (2017)

A critical assessment on the role of sentinel node mapping in endometrial cancer
por: Bogani, Giorgio, et al.
Publicado: (2015)

Imaging in the diagnosis of progressive supranuclear palsy
por: Smith, Matthew D., et al.
Publicado: (2018)

Zolpidem in Progressive Supranuclear Palsy
por: Dash, Sandip K.
Publicado: (2013)

Genetics of Progressive Supranuclear Palsy
por: Im, Sun Young, et al.
Publicado: (2015)

Falls in Progressive Supranuclear Palsy
por: Brown, Fraser S., et al.
Publicado: (2019)

Pulmonary and critical care training in the USA
por: Merrick, Christopher, et al.
Publicado: (2017)

An unusual progressive stridor
por: Apraxine, Matveï, et al.
Publicado: (2020)

Altered network stability in progressive supranuclear palsy
por: Whiteside, David J, et al.
Publicado: (2021)

Assessing ethical climates in critical care and their impact on patient outcomes
por: Okenyi, Emmanuel, et al.
Publicado: (2019)

Postural Stabilization Differences in Idiopathic Parkinson’s Disease and Progressive Supranuclear Palsy during Self-Triggered Fast Forward Weight Lifting
por: Kammermeier, Stefan, et al.
Publicado: (2018)

Treating Leaky Syndrome in the Over 65s: Progress and Challenges
por: Jain, Shalini, et al.
Publicado: (2023)

‘Hummingbird’ sign in progressive supranuclear palsy
por: Shukla, Rakesh, et al.
Publicado: (2009)

Clinical Approach to Progressive Supranuclear Palsy
por: Ling, Helen
Publicado: (2016)

Managing cognition in progressive supranuclear palsy
por: Rittman, Timothy, et al.
Publicado: (2016)

Hummingbird sign in progressive supranuclear palsy
por: Verma, Rajesh, et al.
Publicado: (2012)

Multireceptor fingerprints in progressive supranuclear palsy
por: Chiu, Wang Zheng, et al.
Publicado: (2017)

Frontrunner in Translation: Progressive Supranuclear Palsy
por: Shoeibi, Ali, et al.
Publicado: (2019)

Progressive supranuclear palsy: diagnosis and management
por: Rowe, James B, et al.
Publicado: (2021)

Understanding fatigue in progressive supranuclear palsy
por: Ahn, Jong Hyeon, et al.
Publicado: (2021)

Autonomic dysfunction in progressive supranuclear palsy
por: Baschieri, Francesca, et al.
Publicado: (2022)

Clinical features of progressive supranuclear palsy
por: Wen, Yafei, et al.
Publicado: (2023)

Neurophysiological consequences of synapse loss in progressive supranuclear palsy
por: Adams, Natalie E, et al.
Publicado: (2022)

An interesting case of progressive dyspnoea and diffuse mediastinal adenopathy in a 25-year-old man
por: Cullivan, Sarah, et al.
Publicado: (2021)

Interstitial lung abnormalities a risk factor for rheumatoid arthritis interstitial lung disease progression: what's new
por: Leone, Paolo Maria, et al.
Publicado: (2020)

An Evidence-Based Multidisciplinary Approach Focused at Creating Algorithms for Targeted Therapy of BSIs, cUTIs, and cIAIs Caused by Enterobacterales in Critically Ill Adult Patients
por: Gatti, Milo, et al.
Publicado: (2021)

Advancing functional dysconnectivity and atrophy in progressive supranuclear palsy
por: Brown, Jesse A., et al.
Publicado: (2017)

Putting lung function reference equations into context
por: Borg, Brigitte M., et al.
Publicado: (2021)

Neuroinflammation predicts disease progression in progressive supranuclear palsy
por: Malpetti, Maura, et al.
Publicado: (2021)

A case of atypical progressive supranuclear palsy
por: Spaccavento, Simona, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_mu7so7otmogfrdb73aa6mi6d9e